ADPTQ Adeptus Health

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces the Commencement of an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of Adeptus Health Inc.

NEW YORK--(BUSINESS WIRE)--

Levi & Korsinsky announces it has commenced an investigation of Adeptus Health Inc. (NYSE:ADPT) concerning possible violations of federal securities laws. On March 2, 2017, Adeptus Health revealed that it identified “material weaknesses in its internal control over financial reporting related to revenue recognition, accounts receivable, accounting for a contribution to an unconsolidated joint venture, and accounting for equity in (loss) earnings of unconsolidated joint ventures.” As a result, Adeptus Health is evaluating the effect of these errors in its financial statements for prior periods. On this news, shares of Adeptus Health fell sharply during intraday trading on March 2, 2017. To obtain additional information, go to:

http://zlk.9nl.com/adeptus-health-adpt

or contact Joseph E. Levi, Esq. either via email at [email protected] or by telephone at (212) 363-7500, toll-free: (877) 363-5972.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.

EN
02/03/2017

Underlying

ADPTQAdeptus Health

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Adeptus Health

Free Trial
ADPTQ ADEPTUS HEALTH

Adaptive Biotechnologies Corp: 1 director

A director at Adaptive Biotechnologies Corp sold after exercising options/sold 70,000 shares at 8.530USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company'...

06/21/23 June 21, 2023 1 EN
 PRESS RELEASE
Free
ADPTQ ADEPTUS HEALTH

Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Laws...

NEW YORK--(BUSINESS WIRE)-- Bragar Eagel & Squire, P.C. reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Eastern District of Texas on behalf of all persons or entities who purchased or otherwise acquired Adeptus Health, Inc. (NYSE:ADPT) securities between April 29, 2016 and March 1, 2017 (the “Class Period”). Investors have until May 9, 2017 to apply to the Court to be appointed as lead plaintiff in the lawsuit. The Complaint alleges that throughout the Class Period, Defendants m...

May 4, 2017 1 EN
 PRESS RELEASE
Free
ADPTQ ADEPTUS HEALTH

DEADLINE ALERT: Brower Piven Alerts Shareholders Of Approaching Deadli...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Texas on behalf of purchasers of Adeptus Health Inc. (NYSE: ADPT) (“Adeptus” or the “Company”) securities during the period between April 29, 2016 and March 1, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until May 9, 2017 to seek appointm...

April 14, 2017 1 EN
 PRESS RELEASE
Free
ADPTQ ADEPTUS HEALTH

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses I...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Eastern District of Texas on behalf of purchasers of Adeptus Health Inc. (NYSE: ADPT) (“Adeptus” or the “Company”) securities during the period between April 29, 2016 and March 1, 2017, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until May 9, 2017 to seek appointm...

March 28, 2017 1 EN
 PRESS RELEASE
Free
ADPTQ ADEPTUS HEALTH

ADPT LOSS ALERT: Rosen Law Firm Reminds Adeptus Health Inc. Investors ...

NEW YORK--(BUSINESS WIRE)-- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Adeptus Health Inc. securities (NYSE:ADPT) from April 29, 2016 through March 1, 2017, both dates inclusive (the “Class Period”) of the important May 9, 2017 lead plaintiff deadline in the class action filed by the firm. The lawsuit seeks to recover damages for Adeptus investors under the federal securities laws. To join the Adeptus class action, go to http://www.rosenlegal.com/cases-1066.html or call Phillip Kim, Esq. or Kevin...

March 17, 2017 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch